Generali

Do not overexamine the Solvency figure; the results were in line

17/11/23 -"Generali’s results were in line. The P&C figures were expected to be weak following the warning on its Nat Cat budget. Nonetheless, the Life business provided positive signals as outflows ..."

PDF page sample
Pages
61
Language
English
Published on
17/11/23
Download
You may also be interested by these reports :
21/11/25
Banks have experienced a massive rerating since their 2020 Covid lows. Their P/Book ratios attest to that. At 1.18x they are vastly higher in 2025 ...
20/11/25
Uniqa reported a strong set of Q3 results, with continued positive top-line development and solid profitability. Despite the share price performance ...
19/11/25
Swiss Re’s 3Q25 results were mixed. On the positive side, the Q3 net profit was higher than expected, driven by P&C reinsurance amid a favourable ...
19/11/25
We have reviewed our assumptions following the publication of Swiss Re’s 3Q results. Swiss Re’s 3Q25 performance was mixed. On the positive side, net ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO